This study confirmed that the level of MIP-1β was significantly higher in GN-BSI group than in GP-BSI group (P < .001).[24] The results also showed that the level of MIP-1β in the Fungal-BSI group was significantly higher than that in the GP-BSI group (P < .001). The gene discussed is CCL4; the disease is ganglioneuroma.